CBIO
Closed
Catalyst Biosciences Inc
16.15
+0.01 (+0.06%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 16.14
Day's Range: 16.06 - 16.735
Send
sign up or login to leave a comment!
When Written:
0.207
Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company that develops novel medicines to address serious medical conditions. The company's focus is on the development of proteases, enzymes that play a critical role in physiological processes, and the development of small molecule drugs that target proteases. Catalyst Biosciences is headquartered in South San Francisco, California, and was founded in 2002. The company's pipeline includes potential treatments for hemophilia, complement-mediated diseases, and other rare bleeding disorders. Catalyst Biosciences has partnerships with several pharmaceutical companies, including Pfizer and Biogen. The company is publicly traded on the NASDAQ stock exchange under the ticker symbol CBIO.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








